1. Home
  2. AAPG vs GLNG Comparison

AAPG vs GLNG Comparison

Compare AAPG & GLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • GLNG
  • Stock Information
  • Founded
  • AAPG 2009
  • GLNG 1946
  • Country
  • AAPG China
  • GLNG Bermuda
  • Employees
  • AAPG N/A
  • GLNG N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • GLNG Marine Transportation
  • Sector
  • AAPG Health Care
  • GLNG Consumer Discretionary
  • Exchange
  • AAPG Nasdaq
  • GLNG Nasdaq
  • Market Cap
  • AAPG 3.6B
  • GLNG 4.2B
  • IPO Year
  • AAPG 2025
  • GLNG N/A
  • Fundamental
  • Price
  • AAPG $33.87
  • GLNG $38.37
  • Analyst Decision
  • AAPG Strong Buy
  • GLNG Strong Buy
  • Analyst Count
  • AAPG 3
  • GLNG 4
  • Target Price
  • AAPG $49.00
  • GLNG $51.13
  • AVG Volume (30 Days)
  • AAPG 8.0K
  • GLNG 1.4M
  • Earning Date
  • AAPG 11-19-2025
  • GLNG 01-01-0001
  • Dividend Yield
  • AAPG N/A
  • GLNG 2.64%
  • EPS Growth
  • AAPG N/A
  • GLNG 355.96
  • EPS
  • AAPG N/A
  • GLNG 0.58
  • Revenue
  • AAPG $54,524,554.00
  • GLNG $326,627,000.00
  • Revenue This Year
  • AAPG N/A
  • GLNG $60.83
  • Revenue Next Year
  • AAPG $368.64
  • GLNG N/A
  • P/E Ratio
  • AAPG N/A
  • GLNG $65.28
  • Revenue Growth
  • AAPG N/A
  • GLNG 19.15
  • 52 Week Low
  • AAPG $16.50
  • GLNG $29.56
  • 52 Week High
  • AAPG $48.45
  • GLNG $45.98
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 47.99
  • GLNG 43.47
  • Support Level
  • AAPG $30.93
  • GLNG $37.60
  • Resistance Level
  • AAPG $34.31
  • GLNG $39.51
  • Average True Range (ATR)
  • AAPG 0.81
  • GLNG 1.03
  • MACD
  • AAPG 0.26
  • GLNG -0.18
  • Stochastic Oscillator
  • AAPG 85.99
  • GLNG 26.34

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About GLNG Golar Lng Ltd

Golar LNG Ltd is a midstream LNG company that operates in the transportation, regasification, liquefaction, and trading of LNG. The segment in which the group operates includes Shipping, FLNG (Floating Liquefaction Natural Gas vessels), and Corporate and other. It generates maximum revenue from the FLNG segment.

Share on Social Networks: